AMG
44
-3
C
37
-2
CSCO
53
2
CTAS
64
2
SO
70
-3
TRV
43
-3
CNP
65
-3
COST
69
-4
XYL
43
-4
FLS
50
-3
AMP
73
-2
HAL
41
11
MOS
22
2
OI
26
-2
FCX
47
-9
CB
58
-2
BRK.B
42
2
AEP
56
-2
INTC
47
6
MDLZ
36
4
AMG
44
-3
C
37
-2
CSCO
53
2
CTAS
64
2
SO
70
-3
TRV
43
-3
CNP
65
-3
COST
69
-4
XYL
43
-4
FLS
50
-3
AMP
73
-2
HAL
41
11
MOS
22
2
OI
26
-2
FCX
47
-9
CB
58
-2
BRK.B
42
2
AEP
56
-2
INTC
47
6
MDLZ
36
4
Financhill
Back

Avidbank Holdings Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
52

AVBH
Avidbank Holdings

Last Price:
18.50
Seasonality Move:
0.92%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Buy
52
Avidbank Holdings (AVBH) is a Buy

Is Avidbank Holdings a Buy, Sell or Hold?

  • The current Avidbank Holdings [AVBH] share price is $18.50. The Score for AVBH is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • AVBH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AVBH Stock Price Chart

What is Avidbank Holdings's stock price today?

  • The Avidbank Holdings share price today is $18.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AVBH is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

AVBH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 34.39 Sell
Chaikin Money Flow: 2400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.62 - 18.96) Sell
Bollinger Bands (100): (18.69 - 19.27) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

AVBH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.6 Sell
20-day SMA: 18.74 Sell
50-day SMA: 18.89 Sell
200-day SMA: 20 Sell
8-day EMA: 18.6 Sell
20-day EMA: 18.71 Sell
50-day EMA: 18.86 Sell
200-day EMA: 19.39 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Avidbank Holdings Earnings Growth & AVBH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.13 per share, and an increase next year of $0.20 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Avidbank Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):